The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease

被引:484
作者
Qian, Youcun
Liu, Caini
Hartupee, Justin
Altuntas, Cengiz Zubeyir
Gulen, Muhammet Fatih
Jane-wit, Daniel
Xiao, Jianhua
Lu, Yi
Giltiay, Natalia
Liu, Jinbo
Kordula, Tomasz
Zhang, Qi-Wei
Vallance, Bruce
Swaidani, Shadi
Aronica, Mark
Tuohy, Vincent K.
Hamilton, Thomas
Li, Xiaoxia [1 ]
机构
[1] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[3] Virginia Commonwealth Univ, Dept Biochem, Sch Med, Richmond, VA 23298 USA
[4] Univ British Columbia, Div Gastroenterol, Vancouver, BC V6T 1Z4, Canada
[5] BC Childrens Hosp, Vancouver, BC V6T 1Z4, Canada
[6] Cleveland Clin Fdn, Dept Pathobiol, Cleveland, OH 44195 USA
关键词
D O I
10.1038/ni1439
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper cells that produce interleukin 17 (IL-17) are associated with inflammation and the control of certain bacteria. We report here the essential involvement of the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses. After stimulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by recruitment of the kinase TAK1 and E3 ubiquitin ligase TRAF6, which mediate 'downstream' activation of transcription factor NF-kappa B. IL-17-induced expression of inflammation-related genes was abolished in Act1-deficient primary astroglial and gut epithelial cells. This reduction was associated with much less inflammatory disease in vivo in both autoimmune encephalomyelitis and dextran sodium sulfate-induced colitis. Our data show that Act1 is essential in IL-17-dependent signaling in autoimmune and inflammatory disease.
引用
收藏
页码:247 / 256
页数:10
相关论文
共 43 条
[1]  
Awane M, 1999, J IMMUNOL, V162, P5337
[2]   Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain [J].
Becher, Burkhard ;
Bechmann, Ingo ;
Greter, Melanie .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2006, 84 (07) :532-543
[3]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[4]   Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis [J].
Chen, Y ;
Langrish, CL ;
Mckenzie, B ;
Joyce-Shaikh, B ;
Stumhofer, JS ;
McClanahan, T ;
Blumenschein, W ;
Churakovsa, T ;
Low, J ;
Presta, L ;
Hunter, CA ;
Kastelein, RA ;
Cua, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1317-1326
[5]   Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop [J].
Chen, Y ;
Thai, P ;
Zhao, YH ;
Ho, YS ;
DeSouza, MM ;
Wu, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :17036-17043
[6]   Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[7]   Immune function of astrocytes [J].
Dong, YS ;
Benveniste, EN .
GLIA, 2001, 36 (02) :180-190
[8]   Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research [J].
Gold, Ralf ;
Linington, Christopher ;
Lassmann, Hans .
BRAIN, 2006, 129 :1953-1971
[9]  
Han YL, 2000, GLIA, V30, P1
[10]   Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].
Harrington, LE ;
Hatton, RD ;
Mangan, PR ;
Turner, H ;
Murphy, TL ;
Murphy, KM ;
Weaver, CT .
NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132